Enhancing antibacterial immunotherapy for bacterial pneumonia via nanovaccines coated with outer membrane vesicles
Authors:
- Yang WuYWYang Wu
- Guiyun DengGDGuiyun Deng
- Zhiyong SongZSZhiyong Song
- Kai ZhangKZKai Zhang
- Jiamin DengJDJiamin Deng
- Kai JiangKJKai Jiang
- Heyou HanHHHeyou Han
- 4 February 2022
- journal article
- research article
- Published by Elsevier in Chemical Engineering Journal
- Vol. 436
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Major Project of Guangxi
- National Natural Science Foundation of China
This publication has 44 references indexed in Scilit:
- Mesoporous systems for poorly soluble drugsInternational Journal of Pharmaceutics, 2013
- Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenzaInternational Journal of Infectious Diseases, 2012
- Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cellsCellular Microbiology, 2010
- Gram‐positive bacteria produce membrane vesicles: Proteomics‐based characterization of Staphylococcus aureus ‐derived membrane vesiclesProteomics, 2009
- International Study of the Prevalence and Outcomes of Infection in Intensive Care UnitsJAMA, 2009
- Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthmaNature Medicine, 2008
- Global proteomic profiling of native outer membrane vesicles derived from Escherichia coliProteomics, 2007
- Pseudomonas aeruginosa chronic colonization in cystic fibrosis patientsCurrent Opinion in Pediatrics, 2007
- NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptorBlood, 2005
- Pseudomonas aeruginosa Cell-to-Cell Signaling Is Required for Virulence in a Model of Acute Pulmonary InfectionInfection and Immunity, 2000